While most studies have focused on hematological malignancies, particularly acute myeloid leukemia, where ClpP activation leads to mitochondrial dysfunction and selective cancer cell death, its role in solid tumors—especially brain tumors-remains comparatively underexplored. This evidence concerns the gene CLPP and acute myeloid leukemia.